• Facebook Social Icon
  • Twitter Social Icon
  • Instagram Social Icon

Irritable Bowel Syndrome

Study Name: Irritable Bowel Syndrome

Clinics: Barnsley, Blackpool, Cannock, Leeds, Liverpool, Manchester and Teesside.

Therapy Area: Irritable Bowel Syndrome

Gender and Age: Males & Females Aged 18-70

Description: 

IBS is a common condition of the digestive system that affects around 10-15% of adults. It can cause symptoms like abdominal pain or discomfort, stomach cramps, bloating, diarrhoea and constipation.

 

This trial will test the effect of Blautix® (the investigational study drug) compared to placebo (inactive pill) on symptoms of irritable bowel syndrome. There will be 5 visits to one of our clinics over approximately 16 weeks. The study drug or placebo is to be taken orally as two capsules, twice daily.

Reimbursement: Up to £150 plus reasonable travel

Criteria:

Key Inclusion Criteria:

  • Male or female aged 18 – 70 years

  • Diagnosis of IBS

  • Abdominal pain at least once a week due to IBS

  • BMI 18 – 39 kg/m2.

Key Exclusion Criteria:

  • Diagnosis of lactose intolerance or Coeliac disease

  • Significant changes to diet in the last 3 months

 

Other eligibility criteria will apply. Please contact MAC for more information.

Any other information

Eligible patients will receive a comprehensive health screen and study participation will be in collaboration with the patient’s treating physician.